nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute myeloblastic leukemia in adult patients: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Fey, M. |
|
|
19 |
S2 |
p. ii58-ii59 |
artikel |
2 |
Advanced colorectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Van Cutsem, E.J.D. |
|
|
19 |
S2 |
p. ii33-ii34 |
artikel |
3 |
Cancer, fertility and pregnancy: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Pentheroudakis, G. |
|
|
19 |
S2 |
p. ii108-ii109 |
artikel |
4 |
Cancers of unknown primary site: ESMO Clinical Recommendation for diagnosis, treatment and follow-up
|
Briasoulis, E. |
|
|
19 |
S2 |
p. ii106-ii107 |
artikel |
5 |
Cervical cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Haie-Meder, C. |
|
|
19 |
S2 |
p. ii17-ii18 |
artikel |
6 |
Chemotherapy-induced nausea and vomiting: ESMO Clinical Recommendations for prophylaxis
|
Herrstedt, J. |
|
|
19 |
S2 |
p. ii110-ii112 |
artikel |
7 |
Chronic lymphocytic leukemia: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Eichhorst, B. |
|
|
19 |
S2 |
p. ii60-ii62 |
artikel |
8 |
Chronic myelogenous leukemia: ESMO Clinical Recommendations for the diagnosis, treatment and follow-up
|
Hochhaus, A. |
|
|
19 |
S2 |
p. ii63-ii64 |
artikel |
9 |
Colon cancer: ESMO Clinical Recommendations for diagnosis, adjuvant treatment and follow-up
|
Van Cutsem, E.J.D. |
|
|
19 |
S2 |
p. ii29-ii30 |
artikel |
10 |
Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Dummer, R. |
|
|
19 |
S2 |
p. ii86-ii88 |
artikel |
11 |
Differentiated thyroid cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Pacini, F. |
|
|
19 |
S2 |
p. ii99-ii101 |
artikel |
12 |
Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Tilly, H. |
|
|
19 |
S2 |
p. ii67-ii69 |
artikel |
13 |
Editorial board
|
|
|
|
19 |
S2 |
p. ii-iii |
artikel |
14 |
Endometrial carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Baekelandt, M.M. |
|
|
19 |
S2 |
p. ii19-ii20 |
artikel |
15 |
Epithelial ovarian carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Aebi, S. |
|
|
19 |
S2 |
p. ii14-ii16 |
artikel |
16 |
Erythropoietins in cancer patients: ESMO Recommendations for use
|
Greil, R. |
|
|
19 |
S2 |
p. ii113-ii115 |
artikel |
17 |
Esophageal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Stahl, M. |
|
|
19 |
S2 |
p. ii21-ii22 |
artikel |
18 |
Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Paulussen, M. |
|
|
19 |
S2 |
p. ii97-ii98 |
artikel |
19 |
Gastric cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Cunningham, D. |
|
|
19 |
S2 |
p. ii23-ii24 |
artikel |
20 |
Gastric marginal zone lymphoma of MALT type: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Zucca, E. |
|
|
19 |
S2 |
p. ii70-ii71 |
artikel |
21 |
Gastrointestinal stromal tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Casali, P.G. |
|
|
19 |
S2 |
p. ii35-ii38 |
artikel |
22 |
Hematopoietic growth factors: ESMO Recommendations for the applications
|
Greil, R. |
|
|
19 |
S2 |
p. ii116-ii118 |
artikel |
23 |
Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Parikh, P. |
|
|
19 |
S2 |
p. ii27-ii28 |
artikel |
24 |
Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Engert, A. |
|
|
19 |
S2 |
p. ii65-ii66 |
artikel |
25 |
Invasive bladder cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Bellmunt, J. |
|
|
19 |
S2 |
p. ii47-ii48 |
artikel |
26 |
Locally recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Kataja, V. |
|
|
19 |
S2 |
p. ii11-ii13 |
artikel |
27 |
Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Stupp, R. |
|
|
19 |
S2 |
p. ii83-ii85 |
artikel |
28 |
Malignant pleural mesothelioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Stahel, R.A. |
|
|
19 |
S2 |
p. ii43-ii44 |
artikel |
29 |
Management of cancer pain: ESMO Clinical Recommendations
|
Jost, L. |
|
|
19 |
S2 |
p. ii119-ii121 |
artikel |
30 |
Management of oral and gastrointestinal mucositis: ESMO Clinical Recommendations
|
Peterson, D.E. |
|
|
19 |
S2 |
p. ii122-ii125 |
artikel |
31 |
Management of venous thromboembolism in cancer patients: ESMO Clinical Recommendations
|
MandalĂ , M. |
|
|
19 |
S2 |
p. ii126-ii127 |
artikel |
32 |
Mixed or non-seminomatous germ-cell tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Huddart, R. |
|
|
19 |
S2 |
p. ii52-ii54 |
artikel |
33 |
Multiple myeloma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Harousseau, J.-L. |
|
|
19 |
S2 |
p. ii55-ii57 |
artikel |
34 |
Nasopharyngeal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Chan, A.T.C. |
|
|
19 |
S2 |
p. ii81-ii82 |
artikel |
35 |
Neuroendocrine bronchial and thymic tumors: ESMO Clinical Recommendation for diagnosis, treatment and follow-up
|
Oberg, K. |
|
|
19 |
S2 |
p. ii102-ii103 |
artikel |
36 |
Neuroendocrine gastroenteropancreatic tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Oberg, K. |
|
|
19 |
S2 |
p. ii104-ii105 |
artikel |
37 |
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Dreyling, M. |
|
|
19 |
S2 |
p. ii77-ii78 |
artikel |
38 |
Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
D'Addario, G. |
|
|
19 |
S2 |
p. ii39-ii40 |
artikel |
39 |
Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Bielack, S. |
|
|
19 |
S2 |
p. ii94-ii96 |
artikel |
40 |
Pancreatic cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Herrmann, R. |
|
|
19 |
S2 |
p. ii25-ii26 |
artikel |
41 |
Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Pestalozzi, B. |
|
|
19 |
S2 |
p. ii7-ii10 |
artikel |
42 |
Primary cutaneous lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Dummer, R. |
|
|
19 |
S2 |
p. ii72-ii76 |
artikel |
43 |
Prostate cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Horwich, A. |
|
|
19 |
S2 |
p. ii45-ii46 |
artikel |
44 |
Rectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Glimelius, B. |
|
|
19 |
S2 |
p. ii31-ii32 |
artikel |
45 |
Small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Sørensen, M. |
|
|
19 |
S2 |
p. ii41-ii42 |
artikel |
46 |
Soft tissue sarcomas: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Casali, P.G. |
|
|
19 |
S2 |
p. ii89-ii93 |
artikel |
47 |
Squamous cell carcinoma of the head and neck: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Pivot, X. |
|
|
19 |
S2 |
p. ii79-ii80 |
artikel |
48 |
Table of Contents
|
|
|
|
19 |
S2 |
p. iv |
artikel |
49 |
Testicular seminoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Huddart, R. |
|
|
19 |
S2 |
p. ii49-ii51 |
artikel |